AMY KINNETT: Open Payments
NPI 1699845628 · WESTFIELD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$226 in 10 payments from 7 companies in 2025. Trend: 2023 $518 · 2024 $590 · 2025 $226
Food & beverage: $226
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 1 | $71 |
| Astellas Pharma US Inc | 2 | $38 |
| ABBVIE INC. | 1 | $31 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $28 |
| Novo Nordisk Inc | 2 | $28 |
| MILLICENT US INC | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
Products named: MYFEMBREE, Veozah, BOTOX, Wegovy, INTRAROSA, MOUNJARO.
Industry payments across IN — which companies pay providers there.
